A pan-cancer analysis of MARCH8: molecular characteristics, clinical relevance, and immuno-oncology features
Membrane-associated RING-CH8 (MARCH8) is a member of the recently discovered MARCH family of ubiquitin ligases. MARCH8 has been shown to participate in immune responses. However, the role of MARCH8 in prognosis and immunology in human cancers remains largely unknown. The expression of MARCH8 protein...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Cancer Biology & Therapy |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/15384047.2025.2458773 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832098374890815488 |
|---|---|
| author | Zihan Quan Songqing Fan Hongmei Zheng Yue Ning Yang Yang |
| author_facet | Zihan Quan Songqing Fan Hongmei Zheng Yue Ning Yang Yang |
| author_sort | Zihan Quan |
| collection | DOAJ |
| description | Membrane-associated RING-CH8 (MARCH8) is a member of the recently discovered MARCH family of ubiquitin ligases. MARCH8 has been shown to participate in immune responses. However, the role of MARCH8 in prognosis and immunology in human cancers remains largely unknown. The expression of MARCH8 protein was detected via immunohistochemistry in non-small cell lung cancer (NSCLC) and non-cancerous lung tissues. The study investigated the role of MARCH8 in tumor immunity through pan-cancer analysis of multiple databases. MARCH8 genetic alternations and expression were explored with the cBioPortal, GTEx, and TCGA databases. We investigated the role of MARCH8 expression in clinical relevance, prognosis, tumor immune microenvironment, immune checkpoint (ICP) with a series of bioinformatics tools and methods, such as TISIDB database, ESTIMATE, and CIBERSORT method. MARCH8 expression showed cancer-specific dysregulation and was associated with the prognosis of patients in various cancers. MARCH8 was related to the tumor microenvironment and participated in tumor immune regulation. Furthermore, low expression of MARCH8 was associated with poor prognosis and might serve as an independent prognostic biomarker for NSCLC patients. The comprehensive pan-cancer analysis revealed the potential of MARCH8 in tumor-targeted therapy, and suggested MARCH8 as a promising prognostic and immunological pan-cancer biomarker. |
| format | Article |
| id | doaj-art-f8af1f15594f42a0af8a5fab4444853a |
| institution | Kabale University |
| issn | 1538-4047 1555-8576 |
| language | English |
| publishDate | 2025-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Cancer Biology & Therapy |
| spelling | doaj-art-f8af1f15594f42a0af8a5fab4444853a2025-02-05T12:16:20ZengTaylor & Francis GroupCancer Biology & Therapy1538-40471555-85762025-12-0126110.1080/15384047.2025.2458773A pan-cancer analysis of MARCH8: molecular characteristics, clinical relevance, and immuno-oncology featuresZihan Quan0Songqing Fan1Hongmei Zheng2Yue Ning3Yang Yang4Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, ChinaDepartment of Pathology, The Fourth People’s Hospital of Longgang District, Shenzhen, Guangdong, ChinaMembrane-associated RING-CH8 (MARCH8) is a member of the recently discovered MARCH family of ubiquitin ligases. MARCH8 has been shown to participate in immune responses. However, the role of MARCH8 in prognosis and immunology in human cancers remains largely unknown. The expression of MARCH8 protein was detected via immunohistochemistry in non-small cell lung cancer (NSCLC) and non-cancerous lung tissues. The study investigated the role of MARCH8 in tumor immunity through pan-cancer analysis of multiple databases. MARCH8 genetic alternations and expression were explored with the cBioPortal, GTEx, and TCGA databases. We investigated the role of MARCH8 expression in clinical relevance, prognosis, tumor immune microenvironment, immune checkpoint (ICP) with a series of bioinformatics tools and methods, such as TISIDB database, ESTIMATE, and CIBERSORT method. MARCH8 expression showed cancer-specific dysregulation and was associated with the prognosis of patients in various cancers. MARCH8 was related to the tumor microenvironment and participated in tumor immune regulation. Furthermore, low expression of MARCH8 was associated with poor prognosis and might serve as an independent prognostic biomarker for NSCLC patients. The comprehensive pan-cancer analysis revealed the potential of MARCH8 in tumor-targeted therapy, and suggested MARCH8 as a promising prognostic and immunological pan-cancer biomarker.https://www.tandfonline.com/doi/10.1080/15384047.2025.2458773MARCH8pan-cancer analysistumor immune infiltratingE3-ubiquitin ligaseNSCLC |
| spellingShingle | Zihan Quan Songqing Fan Hongmei Zheng Yue Ning Yang Yang A pan-cancer analysis of MARCH8: molecular characteristics, clinical relevance, and immuno-oncology features Cancer Biology & Therapy MARCH8 pan-cancer analysis tumor immune infiltrating E3-ubiquitin ligase NSCLC |
| title | A pan-cancer analysis of MARCH8: molecular characteristics, clinical relevance, and immuno-oncology features |
| title_full | A pan-cancer analysis of MARCH8: molecular characteristics, clinical relevance, and immuno-oncology features |
| title_fullStr | A pan-cancer analysis of MARCH8: molecular characteristics, clinical relevance, and immuno-oncology features |
| title_full_unstemmed | A pan-cancer analysis of MARCH8: molecular characteristics, clinical relevance, and immuno-oncology features |
| title_short | A pan-cancer analysis of MARCH8: molecular characteristics, clinical relevance, and immuno-oncology features |
| title_sort | pan cancer analysis of march8 molecular characteristics clinical relevance and immuno oncology features |
| topic | MARCH8 pan-cancer analysis tumor immune infiltrating E3-ubiquitin ligase NSCLC |
| url | https://www.tandfonline.com/doi/10.1080/15384047.2025.2458773 |
| work_keys_str_mv | AT zihanquan apancanceranalysisofmarch8molecularcharacteristicsclinicalrelevanceandimmunooncologyfeatures AT songqingfan apancanceranalysisofmarch8molecularcharacteristicsclinicalrelevanceandimmunooncologyfeatures AT hongmeizheng apancanceranalysisofmarch8molecularcharacteristicsclinicalrelevanceandimmunooncologyfeatures AT yuening apancanceranalysisofmarch8molecularcharacteristicsclinicalrelevanceandimmunooncologyfeatures AT yangyang apancanceranalysisofmarch8molecularcharacteristicsclinicalrelevanceandimmunooncologyfeatures AT zihanquan pancanceranalysisofmarch8molecularcharacteristicsclinicalrelevanceandimmunooncologyfeatures AT songqingfan pancanceranalysisofmarch8molecularcharacteristicsclinicalrelevanceandimmunooncologyfeatures AT hongmeizheng pancanceranalysisofmarch8molecularcharacteristicsclinicalrelevanceandimmunooncologyfeatures AT yuening pancanceranalysisofmarch8molecularcharacteristicsclinicalrelevanceandimmunooncologyfeatures AT yangyang pancanceranalysisofmarch8molecularcharacteristicsclinicalrelevanceandimmunooncologyfeatures |